These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 16110408)

  • 1. [Therapy of hormone refractory prostate cancer: new standards, new trends].
    Wülfing C; Bierer S; Bögemann M; Piechota H; Hertle L
    Aktuelle Urol; 2005 Aug; 36(4):342-8. PubMed ID: 16110408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hormone-refractory metastatic prostate carcinoma -- combination improves survival].
    Aktuelle Urol; 2005 Sep; 36(5):385-7. PubMed ID: 16163602
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic options for hormone-refractory prostate cancer in 2007.
    Hadaschik BA; Gleave ME
    Urol Oncol; 2007; 25(5):413-9. PubMed ID: 17826663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New approaches in hormone refractory prostate cancer.
    Sonpavde G; Hutson TE
    Am J Clin Oncol; 2006 Apr; 29(2):196-201. PubMed ID: 16601442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel approaches to treating the asymptomatic hormone-refractory prostate cancer patient.
    Gulley J; Dahut WL
    Urology; 2003 Dec; 62 Suppl 1():147-54. PubMed ID: 14747053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New targeted therapies in hormone-refractory prostate cancer].
    Oudard S; Banu E; Scotte F; Beuzeboc P; Guyader C; Medioni J
    Bull Cancer; 2007 Jul; 94(7 Suppl):F62-8. PubMed ID: 17845995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormone-refractory prostate cancer].
    Alexandre I; Rixe O
    Ann Urol (Paris); 2007 Apr; 41(2):47-55. PubMed ID: 17486912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone refractory prostate cancer: Management and advances.
    Sonpavde G; Hutson TE; Berry WR
    Cancer Treat Rev; 2006 Apr; 32(2):90-100. PubMed ID: 16458434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effective chemotherapy for hormone-refractory prostate cancer: docetaxel-prednisone].
    Batman E; de Wit R
    Ned Tijdschr Geneeskd; 2005 Oct; 149(44):2442-5. PubMed ID: 16285357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New standards in the chemotherapy of metastatic hormone-refractory prostate cancer.
    Sava T; Basso U; Porcaro A; Cetto GL
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):53-62. PubMed ID: 15757438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current studies with docetaxel in hormone-refractory prostate cancer: selected presentations from the 27th European Society for Medical Oncology Congress, 2002.
    DeGrendele H
    Clin Prostate Cancer; 2003 Mar; 1(4):212-4. PubMed ID: 15040878
    [No Abstract]   [Full Text] [Related]  

  • 12. [The treatment of castration-resistant prostate cancer].
    Petrányi Á
    Magy Onkol; 2012 Dec; 56(4):219-28. PubMed ID: 23236591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial comment on: combination of bevacizumab and docetaxel in docetaxel-pretreated hormone-refractory prostate cancer: a phase 2 study.
    Oudard S
    Eur Urol; 2008 Nov; 54(5):1094-6. PubMed ID: 18276066
    [No Abstract]   [Full Text] [Related]  

  • 14. Current chemotherapeutic approaches for androgen-independent prostate cancer.
    Rumohr JA; Chang SS
    Curr Opin Investig Drugs; 2006 Jun; 7(6):529-33. PubMed ID: 16784023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cabazitaxel in prostate cancer: stretching a string.
    Dorff TB; Quinn DI
    Lancet; 2010 Oct; 376(9747):1119-20. PubMed ID: 20888974
    [No Abstract]   [Full Text] [Related]  

  • 16. The current role of chemotherapy in metastatic hormone-refractory prostate cancer.
    Petrylak DP
    Urology; 2005 May; 65(5 Suppl):3-7; discussion 7-8. PubMed ID: 15885271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent docetaxel studies establish a new standard of care in hormone refractory prostate cancer.
    Van Poppel H
    Can J Urol; 2005 Feb; 12 Suppl 1():81-5. PubMed ID: 15780173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hormonoresistant metastatic prostate cancer: analysis of two phase III clinical studies].
    Ferrero JM
    Bull Cancer; 2005 May; 92(5):425-7. PubMed ID: 15932803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trials in metastatic prostate cancer--has there been real progress in the past decade?
    Bhandari MS; Petrylak DP; Hussain M
    Eur J Cancer; 2005 Apr; 41(6):941-53. PubMed ID: 15808960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update in the management of patients with hormone-refractory prostate cancer.
    Moore CN; George DJ
    Curr Opin Urol; 2005 May; 15(3):157-62. PubMed ID: 15815191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.